{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:18Z","timestamp":1707524058414},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,7]]},"DOI":"10.7759\/cureus.9041","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T11:49:10Z","timestamp":1594122550000},"source":"Crossref","is-referenced-by-count":1,"title":["Shock From Twisting Peaks: A Rare Case of Recurrent Torsades de Pointes Secondary to Leuprolide-Induced Prolonged QT"],"prefix":"10.7759","author":[{"given":"Danish","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saif","family":"Faiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ejaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug-induced QT prolongation and torsades de pointes","volume":"89","author":"Yap YG","year":"2003","unstructured":"Yap YG, Camm AJ. Drug-induced QT prolongation and torsades de pointes. Heart. 2003, 89:1363-1372. 10.1136\/heart.89.11.1363","journal-title":"Heart"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes","volume":"67","author":"Schwartz PJ","year":"2016","unstructured":"Schwartz PJ, Woosley RL. Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol. 2016, 67:1639-1650. 10.1016\/j.jacc.2015.12.063","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2003.10.002","article-title":"Assessing predictors of drug-induced torsades de pointes","volume":"24","author":"Belardinelli L","year":"2003","unstructured":"Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsades de pointes. Trends Pharmacol Sci. 2003, 24:619-625. 10.1016\/j.tips.2003.10.002","journal-title":"Trends Pharmacol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000085057.63483.9b","article-title":"Torsades de pointes due to noncardiac drugs: Most patients have easily identifiable risk factors","volume":"82","author":"Zeltser D","year":"2003","unstructured":"Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S. Torsades de pointes due to noncardiac drugs: Most patients have easily identifiable risk factors. Medicine. 2003, 82:282-290. 10.1097\/01.md.0000085057.63483.9b","journal-title":"Medicine"},{"key":"ref5","article-title":"Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death","volume":"26","author":"Straus SMJM","year":"2005","unstructured":"Straus SMJM, Sturkenboom MCJM, Bleumink GS, et al.. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005, 26:2007-2012. https:\/\/doi.org\/10.1093\/eurheartj\/ehi312","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht089","article-title":"The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy","volume":"34","author":"Schwartz PJ","year":"2013","unstructured":"Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J. 2013, 34:3109-3116. 10.1093\/eurheartj\/eht089","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.6.616","article-title":"Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome","volume":"101","author":"Moss AJ","year":"2000","unstructured":"Moss AJ, Zareba W, Hall WJ, et al.. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000, 101:616-623. 10.1161\/01.cir.101.6.616","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.046","article-title":"Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: Higher recurrence of events under metoprolol","volume":"60","author":"Chockalingam P","year":"2012","unstructured":"Chockalingam P, Crotti L, Girardengo G, et al.. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: Higher recurrence of events under metoprolol. J Am Coll Cardiol. 2012, 60:2092-2099. 10.1016\/j.jacc.2012.07.046","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.11.1851","article-title":"Leuprolide acetate: a drug of diverse clinical applications","volume":"16","author":"Wilson AC","year":"2007","unstructured":"Wilson AC, Meethal SV, Bowen RL, Atwood CS. Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs. 2007, 16:1851-1863. 10.1517\/13543784.16.11.1851","journal-title":"Expert Opin Investig Drugs"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.004","article-title":"Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413","volume":"21","author":"Roach M 3rd","year":"2003","unstructured":"Roach M 3rd, DeSilvio M, Lawton C, et al.. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol. 2003, 21:1904-1911. 10.1200\/JCO.2003.05.004","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.01.047","article-title":"Metabolic complications of androgen deprivation therapy for prostate cancer","volume":"181","author":"Saylor PJ","year":"2009","unstructured":"Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2009, 181:1998-2008. 10.1016\/j.juro.2009.01.047","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.08.012","article-title":"Cardiovascular safety of degarelix: Results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer","volume":"184","author":"Smith MR","year":"2010","unstructured":"Smith MR, Klotz L, Persson BE, Olesen TK, Wilde AA. Cardiovascular safety of degarelix: Results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer. J Urol. 2010, 184:2313-2319. 10.1016\/j.juro.2010.08.012","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.90140.4578","article-title":"The effect of hormonal therapy for prostate cancer on the electrocardiographic QT interval: phase 3 results following treatment with leuprolide and goserelin, alone or with bicalutamide, and the GnRH antagonist abarelix","volume":"22","author":"Garnick MB","year":"2004","unstructured":"Garnick MB, Pratt CM, Campion M, Shipley J. The effect of hormonal therapy for prostate cancer on the electrocardiographic QT interval: phase 3 results following treatment with leuprolide and goserelin, alone or with bicalutamide, and the GnRH antagonist abarelix. J Clin Oncol. 2004, 22:4578. 10.1200\/jco.2004.22.90140.4578","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/35991-shock-from-twisting-peaks-a-rare-case-of-recurrent-torsades-de-pointes-secondary-to-leuprolide-induced-prolonged-qt","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:54Z","timestamp":1707506514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/35991-shock-from-twisting-peaks-a-rare-case-of-recurrent-torsades-de-pointes-secondary-to-leuprolide-induced-prolonged-qt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.9041","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,7]]}}}